Canterbury DHB

Context

December 2019

don't forget to update the issue and next review variables!!!

Changes in this release

Topic or section

Brief description

Reviewer

Drug Usage in Haematology

Under Non-Hodgkin Lymphoma, we've:

  • removed the R-hyper CVAD and R-MTX ARA C charts.
  • replaced the hyper CVAD cycles 5 and 7, MTX cytarabine cycles 6 and 8, ritux hyper CVAD cycles 1 and 3, and MTX cytarabine cycles 2 and 4 charts with the R-Hyper CVAD and R-Methotrexate Cytarabine charts.
  • renamed the Mantle cell R Maxi-CHOP and Mantle cell R High Dose Cytarabine charts to "Nordic protocol - R Maxi-CHOP" and "Nordic protocol - R High Dose Cytarabine".
  • renamed "CODOX-M - patients all ages" to "R CODOX-M - patients all ages".

Caroline Innes

Drug Usage in Haematology

We've removed, renamed, and added charts under Chronic Lymphocytic Leukaemia.

Tim Vincent

Administration

We've updated the Registrar Handy Hints document.

Lizzie Collin

About this Canterbury DHB document (695934):

Document Owner:

Not assigned (see Who's Who)

Issue Date:

Next Review:

Keywords:

Note: Only the electronic version is controlled. Once printed, this is no longer a controlled document. Disclaimer

Topic Code: 695934